| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kymera Therapeutics, Inc. (KYMR) has 15 insiders with recent SEC Form 4 filings, including 2 buys and 34 sells. KYMR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.96M | $664.52M | - | |
| Dir | 3.97M | $331.97M | - | |
| Dir | 2.80M | $233.77M | - | |
| CEO | 679.2K | $56.73M | -30,000 | |
| CFO | 227.4K | $18.99M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | Mainolfi Nello71 | Chief Executive Officer | Sale+OE | 30,000 | $81.18 | $2,435,377.20 | -1.5% | - | - | |
| Apr 15, 2026 | Chadwick Jeremy G | Chief Operating Officer | Sale+OE | 6,551 | $90.00 | $589,598.40 | -5.1% | - | - | |
| Apr 14, 2026 | Goodman Noah | Chief Business Officer | Sell | 1,347 | $90.00 | $121,230.00 | -2.6% | - | - | |
| Mar 20, 2026 | Esposito Pamela75 | Director | Sale+OE | 2,500 | $79.15 | $197,877.15 | -45.5% | - | - | |
| Mar 11, 2026 | Chadwick Jeremy G | Chief Operating Officer | Sale+OE | 25,758 | $83.30 | $2,145,673.35 | -9.7% | - | - | |
| Dec 31, 2025 | Mainolfi Nello71 | Chief Executive Officer | Sale+OE | 30,000 | $78.06 | $2,341,939.35 | -2.2% | +7.0% | - | |
| Dec 17, 2025 | Esposito Pamela75 | Director | Sale+OE | 27,563 | $82.16 | $2,264,480.27 | -59.0% | -1.0% | - | |
| Dec 12, 2025 | Booth Bruce70 | Director | Sell | 236,588 | $91.72 | $21,699,043.80 | -0.7% | -13.6% | - | |
| Dec 11, 2025 | Baker Bros. Advisors LP59 | Director, 10% Owner | Buy | 2,005,813 | $86.00 | $172,499,918.00 | +30.2% | -7.2% | - | |
| Dec 8, 2025 | Albers Jeffrey W.70 | Director | Sale+OE | 5,000 | $89.76 | $448,823.09 | -68.9% | -9.8% | - |